BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18299340)

  • 1. Leishmania pifanoi proteoglycolipid complex P8 induces macrophage cytokine production through Toll-like receptor 4.
    Whitaker SM; Colmenares M; Pestana KG; McMahon-Pratt D
    Infect Immun; 2008 May; 76(5):2149-56. PubMed ID: 18299340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14.
    Kim S; Kim SY; Pribis JP; Lotze M; Mollen KP; Shapiro R; Loughran P; Scott MJ; Billiar TR
    Mol Med; 2013 May; 19(1):88-98. PubMed ID: 23508573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
    Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
    J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody.
    Colmenares M; Constant SL; Kima PE; McMahon-Pratt D
    Infect Immun; 2002 Dec; 70(12):6597-605. PubMed ID: 12438331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania mexicana lipophosphoglycan activates ERK and p38 MAP kinase and induces production of proinflammatory cytokines in human macrophages through TLR2 and TLR4.
    Rojas-Bernabé A; Garcia-Hernández O; Maldonado-Bernal C; Delegado-Dominguez J; Ortega E; Gutiérrez-Kobeh L; Becker I; Aguirre-Garcia M
    Parasitology; 2014 May; 141(6):788-800. PubMed ID: 24512642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and biological characterization of the protective Leishmania pifanoi amastigote antigen P-8.
    Colmenares M; Tiemeyer M; Kima P; McMahon-Pratt D
    Infect Immun; 2001 Nov; 69(11):6776-84. PubMed ID: 11598050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Toll-like receptors by Burkholderia pseudomallei.
    West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
    BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages.
    Miller YI; Viriyakosol S; Worrall DS; Boullier A; Butler S; Witztum JL
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1213-9. PubMed ID: 15718493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression.
    Medvedev AE; Kopydlowski KM; Vogel SN
    J Immunol; 2000 Jun; 164(11):5564-74. PubMed ID: 10820230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.
    Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G
    J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant.
    Okamoto M; Oh-E G; Oshikawa T; Furuichi S; Tano T; Ahmed SU; Akashi S; Miyake K; Takeuchi O; Akira S; Himeno K; Sato M; Ohkubo S
    Clin Diagn Lab Immunol; 2004 May; 11(3):483-95. PubMed ID: 15138173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition.
    Erridge C; Kennedy S; Spickett CM; Webb DJ
    J Biol Chem; 2008 Sep; 283(36):24748-59. PubMed ID: 18559343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection.
    Pandey SP; Chandel HS; Srivastava S; Selvaraj S; Jha MK; Shukla D; Ebensen T; Guzman CA; Saha B
    J Immunol; 2014 Oct; 193(7):3632-43. PubMed ID: 25194056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway.
    Ben Haij N; Planès R; Leghmari K; Serrero M; Delobel P; Izopet J; BenMohamed L; Bahraoui E
    PLoS One; 2015; 10(6):e0129425. PubMed ID: 26090662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways.
    Netea MG; Kullberg BJ; Galama JM; Stalenhoef AF; Dinarello CA; Van der Meer JW
    Eur J Immunol; 2002 Apr; 32(4):1188-95. PubMed ID: 11932927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania (Viannia) braziliensis amastigotes induces the expression of TNFα and IL-10 by human peripheral blood mononuclear cells in vitro in a TLR4-dependent manner.
    Galdino H; Saar Gomes R; Dos Santos JC; Pessoni LL; Maldaner AE; Marques SM; Gomes CM; Dorta ML; de Oliveira MA; Joosten LA; Ribeiro-Dias F
    Cytokine; 2016 Dec; 88():184-192. PubMed ID: 27649507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM.
    Hise AG; Daehnel K; Gillette-Ferguson I; Cho E; McGarry HF; Taylor MJ; Golenbock DT; Fitzgerald KA; Kazura JW; Pearlman E
    J Immunol; 2007 Jan; 178(2):1068-76. PubMed ID: 17202370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis.
    Soong L; Duboise SM; Kima P; McMahon-Pratt D
    Infect Immun; 1995 Sep; 63(9):3559-66. PubMed ID: 7642292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.